|
|
|
|
|
|
|
|
|
|
Previous: AFEM MEDICAL CORP, 10QSB, EX-3.1, 2000-08-11 |
Next: AFEM MEDICAL CORP, 10QSB, EX-27.1, 2000-08-11 |
<PAGE> 1
EXHIBIT 11.1
A-FEM MEDICAL CORPORATION
CALCULATIONS OF NET LOSS PER SHARE
<TABLE>
<CAPTION>
FOR THE THREE MONTHS FOR THE SIX MONTHS
ENDED JUNE 30 ENDED JUNE 30,
----------------------------- -----------------------------
2000 1999 2000 1999
----------- ----------- ----------- -----------
<S> <C> <C> <C> <C>
Actual weighted average
shares outstanding for 9,579,708 9,498,249 9,567,335 9,485,135
the period
Dilutive common and
preferred stock, options
and warrants using the -- - -- -
treasury stock method(1)
----------- ----------- ----------- -----------
Total shares used in per
share calculations 9,579,708 9,498,249 9,567,335 9,485,135
----------- ----------- ----------- -----------
Net loss $ (439,779) $ (653,246) $ (868,718) $(1,349,361)
----------- ----------- ----------- -----------
Basic and diluted net loss
per share $ (0.05) $ (0.07) $ (0.09) $ (0.14)
=========== =========== =========== ===========
</TABLE>
(1) Preferred stock, warrants and options outstanding are not included, as the
effect would be anti-dilutive.
PAGE 3
|
|